Have your own idea? Try our Stock Screener
Indian (NIFTY) Drug Retail Industry Analysis
UpdatedMar 21, 2025
DataAggregated Company Financials
Companies1
- 7D0.4%
- 3M-16.0%
- 1Y4.2%
- YTDn/a
The Drug Retail is down 1.4% in the last week. Over the last year, the industry has been flat overall. Earnings are forecast to grow by 34% annually.
Industry Valuation and Performance
Has the Indian Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 22 Mar 2025 | ₹85.2b | ₹61.2b | ₹1.3b | 64.4x | 64.4x | 1.4x |
| Mon, 17 Feb 2025 | ₹86.7b | ₹61.2b | ₹1.3b | 65.5x | 65.5x | 1.4x |
| Wed, 15 Jan 2025 | ₹92.7b | ₹60.0b | ₹1.0b | 92.5x | 92.5x | 1.5x |
| Fri, 13 Dec 2024 | ₹101.0b | ₹60.0b | ₹1.0b | 100.8x | 100.8x | 1.7x |
| Sun, 10 Nov 2024 | ₹81.3b | ₹58.3b | ₹760.5m | 106.9x | 106.9x | 1.4x |
| Tue, 08 Oct 2024 | ₹76.6b | ₹58.3b | ₹760.5m | 100.7x | 100.7x | 1.3x |
| Thu, 05 Sep 2024 | ₹85.6b | ₹58.3b | ₹760.5m | 112.5x | 112.5x | 1.5x |
| Sat, 03 Aug 2024 | ₹80.5b | ₹56.2b | ₹654.7m | 123x | 123x | 1.4x |
| Mon, 01 Jul 2024 | ₹81.6b | ₹56.2b | ₹654.7m | 124.6x | 124.6x | 1.5x |
| Wed, 29 May 2024 | ₹84.0b | ₹53.9b | ₹586.6m | 143.2x | 143.2x | 1.6x |
| Fri, 26 Apr 2024 | ₹81.3b | ₹53.9b | ₹586.6m | 138.7x | 138.7x | 1.5x |
| Sun, 24 Mar 2024 | ₹82.1b | ₹53.9b | ₹586.6m | 140x | 140x | 1.5x |
| Tue, 20 Feb 2024 | ₹85.2b | ₹53.9b | ₹586.6m | 145.3x | 145.3x | 1.6x |
| Thu, 18 Jan 2024 | ₹88.9b | ₹51.4b | ₹583.5m | 152.4x | 152.4x | 1.7x |
| Sat, 16 Dec 2023 | ₹89.8b | ₹51.4b | ₹583.5m | 153.9x | 153.9x | 1.7x |
| Mon, 13 Nov 2023 | ₹96.3b | ₹51.4b | ₹583.5m | 166.4x | 165x | 1.9x |
| Wed, 11 Oct 2023 | ₹91.5b | ₹48.5b | ₹503.5m | 181.7x | 181.7x | 1.9x |
| Fri, 08 Sep 2023 | ₹96.5b | ₹48.5b | ₹503.5m | 191.6x | 191.6x | 2x |
| Sun, 06 Aug 2023 | ₹111.9b | ₹45.6b | ₹497.6m | 225x | 225x | 2.5x |
| Tue, 04 Jul 2023 | ₹94.1b | ₹45.6b | ₹497.6m | 189x | 189x | 2.1x |
| Thu, 01 Jun 2023 | ₹96.9b | ₹45.6b | ₹497.6m | 194.7x | 194.7x | 2.1x |
| Sat, 29 Apr 2023 | ₹88.2b | ₹42.7b | ₹349.1m | 252.8x | 252.8x | 2.1x |
| Mon, 27 Mar 2023 | ₹79.9b | ₹42.7b | ₹349.1m | 228.8x | 228.8x | 1.9x |
| Wed, 22 Feb 2023 | ₹72.7b | ₹42.7b | ₹349.1m | 208.1x | 208.1x | 1.7x |
| Fri, 20 Jan 2023 | ₹74.9b | ₹40.1b | ₹386.7m | 193.7x | 193.7x | 1.9x |
| Sun, 18 Dec 2022 | ₹77.5b | ₹40.1b | ₹386.7m | 200.4x | 200.4x | 1.9x |
| Tue, 15 Nov 2022 | ₹73.7b | ₹40.1b | ₹386.7m | 190.7x | 190.7x | 1.8x |
| Thu, 13 Oct 2022 | ₹71.3b | ₹38.2b | ₹524.1m | 136x | 136x | 1.9x |
| Sat, 10 Sep 2022 | ₹87.8b | ₹38.2b | ₹524.1m | 167.5x | 167.5x | 2.3x |
| Mon, 08 Aug 2022 | ₹88.2b | ₹37.8b | ₹958.0m | 92.1x | 92.1x | 2.3x |
| Wed, 06 Jul 2022 | ₹90.7b | ₹37.8b | ₹958.0m | 94.7x | 94.7x | 2.4x |
| Fri, 03 Jun 2022 | ₹104.6b | ₹38.1b | ₹889.1m | 117.7x | 117.7x | 2.7x |
| Sun, 01 May 2022 | ₹118.7b | ₹36.2b | ₹1.0b | 115.9x | 115.9x | 3.3x |
| Tue, 29 Mar 2022 | ₹115.8b | ₹36.2b | ₹1.0b | 113.1x | 113.1x | 3.2x |
Price to Earnings Ratio
113.1x
Current Industry PE
- There is only one company in the Indian Drug Retail industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
- The earnings for companies in the Drug Retail industry have grown 8.9% per year over the last three years.
- Revenues for these companies have grown 19% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Comparison
How does Indian Drug Retail compare with similar industries?
| IN Market | 4.45% | |
| Consumer Staples | 2.65% | |
| Food and Staples Retail | 2.15% | |
| Drug Retail | 0.40% | |
| Food Retail | 2.31% | |
| Big Box Super Stores | 0% | 0 |
| Food Distributors | -1.51% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| MEDPLUS MedPlus Health Services | ₹730.40 | 3.0% +₹2.5b | 6.3% | PE66x |